Trademark: 97466475
Word
ALL IN
Status
Dead
Status Code
606
Status Date
Monday, March 4, 2024
Serial Number
97466475
Mark Type
4000
Filing Date
Monday, June 20, 2022
Published for Opposition
Tuesday, June 6, 2023
Abandoned Date
Monday, March 4, 2024

Trademark Owner History

Classifications
40 Manufacturing services for others in the fields of pharmaceutical preparations, biopharmaceutical preparations, biologics, drug products, DNA plasmids, advanced therapeutic medicinal products (ATMPs), principally cell and gene therapies intended for research, clinical and commercial use in humans for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services in the field of production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research

Trademark Events
Mar 4, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2024
Abandonment - No Use Statement Filed
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 3, 2023
Approved For Pub - Principal Register
May 2, 2023
Examiner's Amendment Entered
May 2, 2023
Notification Of Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment -Written
May 2, 2023
Examiner's Amendment Entered
May 2, 2023
Notification Of Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment -Written
Apr 5, 2023
Teas/Email Correspondence Entered
Apr 5, 2023
Correspondence Received In Law Office
Apr 5, 2023
Teas Response To Office Action Received
Mar 29, 2023
Notification Of Non-Final Action E-Mailed
Mar 29, 2023
Non-Final Action E-Mailed
Mar 29, 2023
Non-Final Action Written
Mar 27, 2023
Assigned To Examiner
Jul 7, 2022
New Application Office Supplied Data Entered
Jun 23, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24